海水淹溺性肺水肿的药物治疗进展  

Advancement in pharmacotherapy of pulmonary edema of seawater drowning

作　　者：谢晓燕[1] 金发光[1] 张博[2] 范启新[1] 张勇[1] 

机构地区：[1]第四军医大学唐都医院呼吸科,西安710038 [2]第四军医大学病理生理教研室,西安710032

出　　处：《国际呼吸杂志》2010年第8期496-499,共4页International Journal of Respiration

基　　金：军队十一五攻关课题（08G-102）

摘　　要：海水淹溺性肺水肿和海水型呼吸窘迫综合征是海水淹溺后导致死亡的主要原因，因此尽快纠正肺水肿是治疗淹溺成功的关键。目前治疗上除机械通气、高压氧得到普遍认同外，规范的药物治疗仍在进一步研究中。此文就淹溺性肺水肿的药物治疗研究进展方面作一综述。Pulmonary edema of seawater drowning and seawater respiratory distress syndrome are the major causes of death induced by seawater drownig. Therefore, treating pulmonary edema in time is the key of a successful treatment. Currently, mechanical ventilation and hyperbaric oxygenation have been commonly recognized as treatment. The study of normative drug treatment is still going on. This paper summarizes the study progress in prarmacotherapy of pulmonary edema of seawater drowning.

关 键 词：海水 淹溺 肺水肿 药物治疗 

分 类 号：R541.63[医药卫生—心血管疾病]